Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples